Australia markets open in 2 hours 28 minutes

OncoSec Medical Incorporated (ONCSQ)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:15PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 596.00
Enterprise value -218.52k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.83
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.01

Trading information

Stock price history

Beta (5Y monthly) -17.99
52-week change 3-99.92%
S&P500 52-week change 324.60%
52-week high 30.1440
52-week low 30.0000
50-day moving average 30.0002
200-day moving average 30.0009

Share statistics

Avg vol (3-month) 3448
Avg vol (10-day) 3N/A
Shares outstanding 55.96M
Implied shares outstanding 65.96M
Float 82.51M
% held by insiders 115.43%
% held by institutions 15.97%
Shares short (31 May 2023) 4192.06k
Short ratio (31 May 2023) 40.34
Short % of float (31 May 2023) 43.70%
Short % of shares outstanding (31 May 2023) 43.22%
Shares short (prior month 28 Apr 2023) 4134.99k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 May 2019
Ex-dividend date 4N/A
Last split factor 21:22
Last split date 309 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 31 July 2022
Most-recent quarter (mrq)31 Jan 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-92.84%
Return on equity (ttm)-410.17%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -32.4M
Net income avi to common (ttm)-29.39M
Diluted EPS (ttm)-14.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.68M
Total cash per share (mrq)1.24
Total debt (mrq)8.46M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.89
Book value per share (mrq)-1.85

Cash flow statement

Operating cash flow (ttm)-24.99M
Levered free cash flow (ttm)-16.43M